A teenager has been awarded $70 million by a jury in his Risperdal lawsuit – the largest jury award to date involving Risperdal litigation. The plaintiff and his mother allege use of Risperdal for a number of years during childhood led to the growth of male breasts, a condition known... Read more »

A settlement has been reached between the Kentucky Attorney General and Johnson & Johnson regarding the schizophrenia drug Risperdal. The lawsuit was originally filed with allegations that the pharmaceutical giant and its subsidiary Janssen Pharmaceuticals hid some of the drug’s side effects from consumers, while marketing it for off-label use... Read more »

Adding to a growing body of research linking Risperdal and gynecomastia in young boys and men, a recent study published in the Journal of Child and Adolescent Psychopharmacology has revealed a correlation between the two following an intense look at over 15,000 cases. The study, which was published online ahead... Read more »

Dr. David Kessler, the former head of the U.S. Food and Drug Administration, claims that a medical article, which was co-authored by SickKids hospital’s top pediatrician, understated the serious nature and rate of Risperdal side effects in younger patients. The authors of the 2003 article were allegedly manipulated by the drug company Janssen,... Read more »

A resident of Minnesota has filed a Risperdal lawsuit, alleging that the medication resulted in gynecomastia and other severe complications. The lawsuit, which was filed in the U.S. District Court for the District of Minnesota, names Johnson & Johnson Company and Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, as... Read more »

Another Risperdal lawsuit over gynecomastia has been filed, this time in Louisiana. Karon-Jahlil Williams v. Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development, L.L.C. (Case # 5:14-cv-03354) was filed on December 2, 2014 in the US. District Court for the Western District of Louisiana (Shreveport Division). The... Read more »

The powerful prescription medication Risperdal, which is classified as an “atypical antipsychotic,” was recently implicated in a federal personal injury lawsuit filed in United States District Court for the Middle District of Louisiana. At the heart of the plaintiff’s complaint is the assertion that her minor child was wrongfully exposed... Read more »

As the wave of lawsuits involving antipsychotic drug Risperdal continues to gain momentum, several key cases are slated for trial in the coming months in Pennsylvania state court. These suits involve allegations made on behalf of males who suffered excessive breast development after taking the medication in their youth. Johnson &... Read more »

Lawsuits have been piling up against Merck & Co. with regard to the defendants’ medication, Propecia (finasteride). The lawsuits typically claim that the drug is unreasonably dangerous and defective, and that it has caused severe side effects. Now, a Florida resident has filed a new Propecia lawsuit claiming breast cancer... Read more »

According to the findings of a new study, published by the Journal of Clinical Psychopharmacology, the powerful antipsychotic drug Risperdal shows a positive correlation to the development of abnormal breast tissue in men – a condition known as gynecomastia. The study specifically concluded that the risk of gynecomastia extends not... Read more »